Most recent deal Thursday, August 20, 2026.
The group's NZCR, CMAX, Optimal and Fusion brands provide integrated Phase I–IV clinical trial capabilities to global pharmaceutical, biotechnology and contract research organization customers.
The deal values the undersea warfare systems provider at $3.45 billion and adds sonar and acoustic sensor capabilities to Lockheed Martin’s defense portfolio.
The defense technology specialist employs 220 people across five U.S. facilities and was sold by Advent International's Cobham Ultra Group for $720 million.
The deal creates a payments platform expected to generate $3 billion in annual revenue and process more than $500 billion in payment volume for over 2.4 million customers.
The deal adds embedded payroll processing and AI-driven operational intelligence to Xplor's vertical SaaS platform, with plans to extend the tools across golf, field services, and education.
